Mumbach, Maxwell R
Satpathy, Ansuman T http://orcid.org/0000-0002-5167-537X
Boyle, Evan A http://orcid.org/0000-0003-4494-9771
Dai, Chao
Gowen, Benjamin G http://orcid.org/0000-0002-1111-3284
Cho, Seung Woo
Nguyen, Michelle L
Rubin, Adam J
Granja, Jeffrey M
Kazane, Katelynn R
Wei, Yuning
Nguyen, Trieu
Greenside, Peyton G
Corces, M Ryan
Tycko, Josh http://orcid.org/0000-0002-4108-0575
Simeonov, Dimitre R http://orcid.org/0000-0002-1693-8664
Suliman, Nabeela
Li, Rui
Xu, Jin
Flynn, Ryan A
Kundaje, Anshul http://orcid.org/0000-0003-3084-2287
Khavari, Paul A http://orcid.org/0000-0003-0098-4989
Marson, Alexander
Corn, Jacob E http://orcid.org/0000-0002-7798-5309
Quertermous, Thomas
Greenleaf, William J http://orcid.org/0000-0003-1409-3095
Chang, Howard Y http://orcid.org/0000-0002-9459-4393
Article History
Received: 27 March 2017
Accepted: 1 September 2017
First Online: 25 September 2017
Competing interests
: H.Y.C. and W.J.G. are co-founders of Epinomics and members of its scientific advisory board. A.K. is a member of the scientific advisory board of Epinomics. A.M. and J.E.C. are co-founders of Spotlight Therapeutics. J.E.C. serves as an advisor to Mission Therapeutics, and the Corn laboratory has received sponsored research support from AstraZeneca and Pfizer. A.M. serves as an advisor to Juno Therapeutics and PACT Therapeutics, and the Marson laboratory has received sponsored research support from Juno Therapeutics and Epinomics.